![Mark Watson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Watson
Director/Miembro de la Junta en
ABRDN HEALTHCARE OPPORTUNITIES FUND
.
Perfil
Mark Watson is currently the Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. since 2009.
He is also currently serving as an Independent Trustee at abrdn Healthcare Opportunities Fund starting in 2022.
Previously, Mr. Watson held positions as Director at Sykes Enterprises, Inc. from 2018 to 2021, Director at BioDelivery Sciences International, Inc. from 2017 to 2022, and Director at Inhibitor Therapeutics, Inc. from 2014 to 2022.
Cargos activos de Mark Watson
| Empresas | Cargo | Inicio |
|---|---|---|
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Director/Miembro de la Junta | 09/06/2022 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Director/Miembro de la Junta | 01/01/2009 |
Antiguos cargos conocidos de Mark Watson.
| Empresas | Cargo | Fin |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Director/Miembro de la Junta | 13/12/2022 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director/Miembro de la Junta | 02/01/2022 |
| SYKES ENTERPRISES, INCORPORATED | Director/Miembro de la Junta | 02/01/2021 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
50
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Sykes Enterprises, Inc.
 Sykes Enterprises, Inc. Information Technology ServicesTechnology Services Provides business process outsourcing services | Technology Services |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Bolsa de valores
- Insiders
- Mark Watson
